Lumida
/NHC
⌘K
National Healthcare Corp

National Healthcare Corp

NHC
$228.16USD+1.57%+3.52 today

MARKET CAP

3.6B

P/E (TTM)

29.0x

FWD P/E

DAY RANGE

$223 – $232

52W RANGE

$94
$232

AI Summary

Stalk
StalkMedium

NHC remains in a Stage 2 advancing regime with medium-term bullish structure intact, but price is extended above rising EMAs and has printed a Bullish Exhaustion candle in extreme overbought conditions. Short-term timing is unfavorable for immediate entry; defer participation and stalk for a pullback into the rising EMA support zone.

  • Acquired 35 facilities for $560M, adding assets accretive to earnings and cash flow.
  • Strong earnings yield at 1.13 and robust profitability support debt servicing.
  • Acquisition added $475M debt, elevating interest costs and leverage risk.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

National HealthCare Corporation (NHC) specializes in operational and management services for senior care facilities, including skilled nursing and independent living facilities. Having recently acquired 35 properties previously under lease from National Health Investors, NHC strengthens its market position amid a growing demand for senior housing, which is a part of the broader trend of an aging population. The company operates in a highly regulated industry but benefits from established relationships and experience in managing healthcare facilities, providing a competitive advantage in a consolidating market.

Bull says

  • Acquired 35 facilities for $560M, adding assets accretive to earnings and cash flow.
  • Strong earnings yield at 1.13 and robust profitability support debt servicing.
  • Shares hit $219.05 52-week high; up ~110% YoY on strong momentum.
  • Low leverage provides balance sheet flexibility to navigate economic downturns.
  • Average analyst rating of 1.67 (Strong Buy) underscores positive sentiment.
  • Secular aging trend drives growing demand for senior housing facilities.

Bear says

  • Acquisition added $475M debt, elevating interest costs and leverage risk.
  • Negative growth outlook and downward earnings revisions may constrain revenue.
  • Dividend yield underwhelms, deterring income-focused investors seeking higher payouts.
  • ETF outflows signal waning institutional support, risking stock pressure.
  • Analysts warn of value trap if cash flows fail to meet projections.
  • Average price target of $17.33 implies significant downside risk.

Investment themes with NHC

Health Care Providers -0.61%

UNH · CVS · HCA
Demographics: Elderly Care -0.26%

Services and products for aging population

UCB.BR · JNJ · AZN